Ip7E

Description:
Ip7E is a neuroprotective agent that has been shown to be effective in the treatment of various neurodegenerative diseases, such as Parkinson’s and Alzheimer’s disease. Ip7E is a small molecule that modulates the metabolism of cells and protects them from death by inducing changes in cell nuclei. It also prevents radiation-induced neuronal cell death. Ip7E has been shown to be effective when administered before or after the onset of disease, suggesting it may be a possible diagnostic for neurodegenerative diseases. Ip7E binds to cellular membranes and stabilizes them against oxidative damage, thus protecting cells from death by apoptosis, necrosis, or autophagy. It also inhibits fatty acid synthase (FAS) activity and hepatic steatosis.Ip7E has not yet been tested on humans but is being investigated as a potential drug target for neuroprotection in various neurological disorders.